University of Colorado, Denver
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Colorado, Denver sits in the top decile of US sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count).
University of Colorado, Denver: 1,283 sponsored US clinical trials, 265 recruiting.
University of Colorado, Denver sponsors 1,283 registered US clinical trials on ClinicalTrials.gov, 265 of them currently recruiting, and 830 completed. 121 of these trials are in Phase 3-4 (later-stage) and 245 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 23 trials.
Top-decile sponsor footprint
University of Colorado, Denver ranks in the top decile of sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
830 of 908 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,283 total, page 7 of 26
Effectiveness of Engaging in Advance Care Planning Talks (ENACT) Group Visits in Primary Care for Older Adults With and Without Alzheimer's Disease
NCT05421728
Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma
NCT05089370
Adherence and Clinical Correlates in Persons With HIV on TAF
NCT05335590
Care Planning Framework in Advanced Cancer (ABC123)
NCT05408507
Critical Windows in the Development of Asthma Endotypes and Phenotypes in High-Risk Toddlers
NCT05210361
Molecular Endotypes of Chronic Idiopathic Urticaria
NCT04774315
CASCADE: CAnnabidiol Study in Children With Autism Spectrum DisordEr
NCT04520685
Effect of Hormones on Frequency of Headache and Brain Structure and Function in Puberty
NCT05607303
Ovarian Hormone Regulation of Central and Cerebrovascular Hemodynamics (NoMEN Study)
NCT05057546
Personalized Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma
NCT04925193
Childhood Obesity Treatment Designed for Low Income and Hispanic Families
NCT05041855
Virtual Exercise Program to Reduce Cancer Related Fatigue
NCT04533165
Daily Caloric Restriction in ADPKD
NCT04907799
Skeletal Effects of Chronic Night Shift
NCT05091021
Facing Your Fears: Adolescents With ASD and Intellectual Disability
NCT05131425
Effects of Complementary Feeding on Infant Growth and Gut Health
NCT05012930
MitoQ Supplementation and Cardiovascular Function in Healthy Men and Women
NCT03586414
Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer
NCT04963283
Comparing Home, Office, and Telehealth Induction for Medication Assisted Treatment for Opioid Use Disorder
NCT04664062
Strategy to Avoid Excessive Oxygen in Major Burn Patients
NCT04534972
High-Intensity Exercise to Attenuate Limitations and Train Habits in Older Adults With HIV
NCT04550676
Developing a Virtual Stress Management Intervention for Spousal/Partnered Caregivers of Solid Tumor Cancer Patients.
NCT04739696
Advancing Prevention of Pulmonary Fibrosis
NCT04564183
Addition of Dehydrated Human Amnion-Chorion Membrane During Scaling and Root Planing
NCT03836378
Strategy to Avoid Excessive Oxygen for Critically Ill Trauma Patients
NCT04534959
Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis Assessed by Transnasal Endoscopy (TNE)
NCT04149470
Tendon-Bone Versus All-Soft-Tissue for ACL Reconstruction: A Patient-Blinded Randomized Clinical Trial
NCT04039971
Identification of Best Postoperative Analgesia Method Following a Minimally Invasive Repair of Pectus Excavatum
NCT04211935
Induction FLOT With CROSS CRT for Esophageal Cancer
NCT04028167
Cisplatin Disposition and Kidney Injury
NCT03817970
Tocilizumab in Children With ACP
NCT03970226
MEtabolic and Renal Effects of AutoMAted Insulin Delivery Systems in Youth With Type 1 Diabetes Mellitus
NCT03945747
Total Joint Arthroplasty in a Pediatric Population
NCT04294693
Longitudinal Innate Immunity and Aging Study
NCT03944603
Rucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer
NCT03617679
Nivolumab for the Reversal of Squamous Dysplasia in High Risk Current and Former Smokers
NCT03347838
Venetoclax and Azacitidine for Non-Elderly Adult Patients With Acute Myeloid Leukemia
NCT03573024
Impact of Sleep Extension in Adolescents
NCT03500458
Omacetaxine + Azacitidine in Untreated Patients With High Grade MDS
NCT03564873
Prospective Evaluation of the Efficacy and Safety of Submucosal Endoscopy
NCT03626350
Azacitidine and Venetoclax as Induction Therapy With Venetoclax Maintenance in the Elderly With AML
NCT03466294
Biomarkers of Immune-Related Toxicity
NCT03409016
Subcortical Oscillations in Human Sleep Dysregulation
NCT03377569
Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer
NCT02955394
Statin Therapy in Patients With Early Stage ADPKD
NCT03273413
Pilot Study of the Effect of Trastuzumab and GM-CSF on Children With Recurrent Ependymoma
NCT02774421
Shorter Course Radiation for the Treatment of Breast Cancer That Has Spread to Lymph Nodes
NCT02700386
Reprometabolic Syndrome Mediates Subfertility in Obesity
NCT02653092
The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis
NCT02389075
Cerebral Palsy Adult Transition Longitudinal Study
NCT02137005
What is open in the University of Colorado, Denver pipeline
265 recruiting of 1,283 indexed (21% open); 830 completed (65%).
Phase mix: 121 late (III/IV) vs 245 early (I/II) (early-phase heavy).
Top condition: Obesity (23 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Colorado, Denver: open-pipeline peers nationwide
Peers matched on 1,283 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,283 trials (± recruiting share)
- AstraZeneca · 1,285 trials · 12% recruiting
- University of Michigan · 1,327 trials · 13% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- Eli Lilly and Company · 1,341 trials · 9% recruiting
Sponsors near 21% open enrollment (± trial volume)
- Cedars-Sinai Medical Center · 21% recruiting · 339 trials
- Craig Hospital · 21% recruiting · 29 trials
- W.L.Gore & Associates · 21% recruiting · 53 trials
- Georgia Institute of Technology · 21% recruiting · 24 trials
Related
What to do with this University of Colorado, Denver page
1,283 registered trials is a research-attention snapshot, not an endorsement of University of Colorado, Denver or any single study.
- 265 of University of Colorado, Denver's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Colorado, Denver studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Colorado, Denver pipeline card: 1,283 registered trials from official public datasets.Report a data error.